Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$17.50

0.85 (5.11%)

07:57
09/28/17
09/28
07:57
09/28/17
07:57

Evolent Health price target lowered to $25 from $35 at Baird

Baird analyst Matthew Gillmor lowered his price target on Evolent Health to $25 to reflect multiple compression, but he believes the valuation remains compelling. The analyst noted its contract wins in Illinois and New Mexico, which provide good visibility into 2018. He does admit renewal risk remains uncertain, but also feels its multiple is overly discounted relative to the company's positioning and growth. Gillmor maintained his Outperform rating on Evolent Health shares.

EVH Evolent Health
$17.50

0.85 (5.11%)

09/20/17
09/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Biogen (BIIB) initiated with a Buy at SunTrust. 2. CymaBay (CBAY) initiated with an Overweight at Cantor. 3. Evolent Health (EVH) initiated with an Overweight at KeyBanc. 4. Epizyme (EPZM) initiated with a Buy at Jefferies. 5. Intuit (INTU) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/17
RHCO
09/20/17
NO CHANGE
RHCO
Evolent Health outlook remains positive, says SunTrust
SunTrust analyst Sandy Draper says that Evolent Health's stock has dropped about 12% since September 8 because the market is worried about the latest Obamacare repeal bill which would cut Federal Medicaid spending and lower the company's total available market as a result. But the analyst, saying that the company has barely penetrated its existing TAM, thinks it can compensate for a lower TAM with share gains. He reiterates a $30 price target and a Buy rating on the stock.
09/19/17
KEYB
09/19/17
INITIATION
Target $23
KEYB
Overweight
Evolent Health initiated with an Overweight at KeyBanc
KeyBanc analyst Donald Hooker started Evolent Health with an Overweight rating and $23 price target. The company offers an attractive way to play the transformation of U.S. healthcare to value-based reimbursement, the analyst contends.
09/06/17
JEFF
09/06/17
NO CHANGE
Target $28
JEFF
Buy
Jefferies calls Evolent 'easy buy' after management meeting
Jefferies analyst Sean Dodge says Evolent Health shares are down 27% since the company's Q2 results on August 7 due to "overblown concerns" around 2018 revenue growth and use of proceeds from the primary share offering. After meeting with management, the analyst notes Evolent remains confident in its long-term outlook and that there are multiple near-term catalyst for the shares. Dodge believes Evolent's revenue will grow 25%-plus in 2018, even without another new client, and the $175M capital raise "foreshadows some big contract wins." He sees "little chance" of another secondary offering now that private equity ownership is mostly removed. Valuation makes Evolent "an easy buy," Dodge tells investors. He recommends buying the shares and keeps a Buy rating on the name with a $28 price target.

TODAY'S FREE FLY STORIES

04:55
10/20/17
10/20
04:55
10/20/17
04:55
General news
Breaking General news story  »

Federal Reserve Chair…

XEC

Cimarex Energy

$115.32

0.29 (0.25%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Cimarex Energy management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 08

    Nov

04:55
10/20/17
10/20
04:55
10/20/17
04:55
General news
Breaking General news story  »

Federal Reserve Chair…

LXRX

Lexicon

$11.34

0.15 (1.34%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Lexicon has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

04:55
10/20/17
10/20
04:55
10/20/17
04:55
General news
Existing Home Sales to be reported at 10:00 »

September Existing Home…

CPST

Capstone Turbine

$1.09

0.01 (0.93%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Capstone Turbine management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

MRK

Merck

$63.75

0.24 (0.38%)

, GSK

GlaxoSmithKline

$41.10

0.09 (0.22%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
European Society of Gene & Cell Therapy will hold a conference »

25th Anniversary Congress…

MRK

Merck

$63.75

0.24 (0.38%)

GSK

GlaxoSmithKline

$41.10

0.09 (0.22%)

TECH

Bio-Techne

$123.46

0.33 (0.27%)

PLL

Pall Corp.

ICEL

Cellular Dynamics

ABEO

Abeona Therapeutics

$17.75

0.25 (1.43%)

KITE

Acquired by GILD 9/17

PFE

Pfizer

$36.24

0.41 (1.14%)

BMRN

BioMarin

$88.13

-0.49 (-0.55%)

SHPG

Shire

$147.82

1.53 (1.05%)

TIG

TiGenix

$24.21

0.91 (3.91%)

BIIB

Biogen

$342.42

-2.16 (-0.63%)

QURE

uniQure

$15.16

5.69 (60.08%)

SGMO

Sangamo

$13.95

-0.2 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 02

    Feb

  • 28

    Feb

  • 17

    Oct

04:55
10/20/17
10/20
04:55
10/20/17
04:55
General news
Breaking General news story  »

Cleveland Federal Reserve…

ADBE

Adobe

$171.73

18.73 (12.24%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Adobe to hold a conference »

Adobe Max: The Creativity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

TGEN

Tecogen

$2.95

-0.0371 (-1.24%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Tecogen management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

BOLD

Audentes Therapeutics

$25.05

-0.36 (-1.42%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call »

Biotech Analyst Prasad,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

04:55
10/20/17
10/20
04:55
10/20/17
04:55
General news
Breaking General news story  »

Week of 10/20…

GME

GameStop

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
GameStop management to meet with Loop Capital »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

VSTM

Verastem

$3.95

0.05 (1.28%)

04:55
10/20/17
10/20
04:55
10/20/17
04:55
Conference/Events
Verastem management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

REGN

Regeneron

$440.94

1.57 (0.36%)

04:50
10/20/17
10/20
04:50
10/20/17
04:50
Downgrade
Regeneron rating change  »

Regeneron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

03:45
10/20/17
10/20
03:45
10/20/17
03:45
General news
FX Action: USD-CAD has rallied back above 1.2500 »

FX Action: USD-CAD has…

02:55
10/20/17
10/20
02:55
10/20/17
02:55
General news
FX Update: The dollar has rallied across the board »

FX Update: The dollar…

01:45
10/20/17
10/20
01:45
10/20/17
01:45
General news
Breaking General news story  »

Federal Reserve Chair…

STLD

Steel Dynamics

$37.78

1.34 (3.68%)

21:35
10/19/17
10/19
21:35
10/19/17
21:35
Upgrade
Steel Dynamics rating change at KeyBanc »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RXDX

Ignyta

$16.65

0.4 (2.46%)

20:30
10/19/17
10/19
20:30
10/19/17
20:30
Syndicate
Ignyta 10M share Secondary priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 20

    Oct

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

, GE

General Electric

$23.58

0.46 (1.99%)

20:25
10/19/17
10/19
20:25
10/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

GE

General Electric

$23.58

0.46 (1.99%)

HON

Honeywell

$143.62

0.18 (0.13%)

SLB

Schlumberger

$64.50

-1.41 (-2.14%)

STI

SunTrust

$59.11

-0.18 (-0.30%)

SYF

Synchrony

$31.71

0.2 (0.63%)

CFG

Citizens Financial

$37.43

0.25 (0.67%)

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

GNTX

Gentex

$20.66

0.2 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.